Research News and Research

RSS

Trained dog sniffs out colon cancer with 98% accuracy

For the study the researchers at Kyushu University trained an 8-year-old female Labrador retriever named Marine who was given breath and stool samples of 306 patients, collected right before they received colonoscopies.

2 Feb 2011

Nutritional supplements and seniors: New study

The University of Adelaide will be embarking on a new study that will look into the benefits of providing nutritional supplements and small doses of hormones to elderly people.

2 Feb 2011

NY Times: New take on concierge medicine

When Jennifer Contreras went to see her new physician, she had hardly arrived in the waiting room before she was called in — by the doctor herself. Ms. Contreras is a patient at One Medical Group, a new model for primary care that aims to set a nationwide example.

2 Feb 2011

Bioengineers and physician-scientists zap tumors with light-activated nanoparticles

Rice University bioengineers and physician-scientists at Baylor College of Medicine and Texas Children's Hospital have successfully destroyed tumors of human brain cancer cells in the first animal tests of a minimally invasive treatment that zaps glioma tumors with heat. The tests involved nanoshells, light-activated nanoparticles that are designed to destroy tumors with heat and avoid the unwanted side effects of drug and radiation therapies.

2 Feb 2011

Scientists discover breast cancer cells that dodge immune system, promote tumor growth

Scientists discovered a new way breast cancer cells dodge the immune system and promote tumor growth, providing a fresh treatment target in the fight against the disease. While comparable mechanisms to avoid the immune system have been identified in mice with breast and other cancers, the study tested human breast tumor cells, putting researchers closer to understanding how the disease progresses in real patients.

2 Feb 2011

Daily probiotic may help prevent upper respiratory tract infections in athletes: Research

Researchers at Loughborough University have revealed that a simple, daily probiotic might help prevent athletes catching colds during their training and competition.

2 Feb 2011

Intrexon announces AgBio Division launch and Agarigen acquisition

Intrexon Corporation, a next generation synthetic biology company, today announced the launch of its Agricultural Biotechnology (AgBio) Division in Research Triangle Park, North Carolina and the acquisition of Agarigen, Inc., a North Carolina-based company that has developed a novel, mushroom-based expression platform for the rapid, high yield production of recombinant proteins.

2 Feb 2011

In-depth analysis of health law decision

News outlet examine how constitutional issues, most notably the Commerce Clause, are central to the health law and its journey to the nation's highest court. Meanwhile, the Associated Press offers insights into Judge Vinson's own experiences with the health system.

2 Feb 2011

Pregnant women eating baked clay at risk of cancer, kidney damage and brain damage

Pregnant women eating baked clay could be exposing themselves and their unborn child to toxic chemicals, according to research by De Montfort University (DMU) in Leicester, UK.

2 Feb 2011

Scientists test new dry powder measles vaccine that can be inhaled

Sustained high vaccination coverage is key to preventing deaths from measles. Despite the availability of a vaccine, measles remains an important killer of children worldwide, particularly in less-developed regions where vaccination coverage is limited. A team of researchers, led by scientists at the Johns Hopkins Bloomberg School of Public Health and the University of Colorado, developed and successfully tested a dry powder, live-attenuated measles vaccine that can be inhaled.

2 Feb 2011

Research discovers new role of TRPV1 receptors in regulation of locomotor activity

Research by a Barrow Neurological Institute scientist on the thermoregulatory effects of a receptor more commonly studied for its role in pain is the cover story in the Feb. 2 issue of the Journal of Neuroscience.

2 Feb 2011

Antares initiates dosing in VIBEX MTX clinical study for rheumatoid arthritis

Antares Pharma, Inc. today announced that the first patient has been dosed in a clinical study evaluating the VIBEX™ MTX product which is being developed for the treatment of rheumatoid arthritis. The clinical study will evaluate several dose strengths of VIBEX MTX delivered with a proprietary autoinjector versus conventional needle and syringe administration by a healthcare professional.

2 Feb 2011

Study finds link between oral health care and heart disease

During American Heart Month in February, United Concordia Dental, one of the nation's largest dental insurers, wants to remind adults that taking care of their teeth and gums is an important part of promoting heart health.

2 Feb 2011

Senate GOP leaders advance efforts to force health law repeal vote

Politico: "Senate Minority Leader Mitch McConnell told Republicans Tuesday that he plans to force a vote on repealing the health care reform law this week. The plan is to tack the amendment onto the Federal Aviation Administration reauthorization bill this afternoon, a Republican aide told POLITICO. McConnell told Republicans of the plan in their weekly policy lunch" (Haberkorn, 2/1).

2 Feb 2011

EA sponsors research grant to investigate specific cancers and kinase mutations

Expression Analysis today announced a jointly sponsored research grant for up to eight American Cancer Society Grantees to investigate and draw parallels between specific cancers and recurring mutations in specific kinases, using targeted genome sequencing.

2 Feb 2011

Some insurers join forces for health law lobbying efforts

Top executives from UnitedHealth Group Inc. and WellPoint Inc. are meeting almost monthly with their counterparts from Aetna Inc., Cigna Corp. and Humana Inc. in an informal lobbying alliance aimed at blunting parts of the health-care law, say people with knowledge of the sessions.

2 Feb 2011

PET imaging may play a role in early evaluation of vandetanib response in thyroid cancer

Positron emission tomography can image metabolic changes following treatment with the protein kinase inhibitor vandetanib, helping to define the therapy response or the effectiveness of the therapeutic agent, according to research published in the February issue of The Journal of Nuclear Medicine.

1 Feb 2011

FDA, Optivia collaborate to examine effect of dietary supplements in drug-induced liver injury

Optivia Biotechnology, a leading provider of in vitro transporter assay services, today announced that the company and the U.S. Food and Drug Administration have signed a collaboration agreement to assess the effect of dietary supplements on key drug transporters.

1 Feb 2011

Intricon introduces new patent-pending APT Open in-the-canal hearing aid

IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn devices, today announced that it has launched its all-new, patent-pending APT Open in-the-canal hearing aid.

1 Feb 2011

OPKO Health acquires CURNA

OPKO Health, has acquired CURNA, a privately held company based in Jupiter, Florida, engaged in the discovery of new drugs for the treatment of a wide variety of illnesses, such as cancer, heart disease, metabolic disorders and genetic anomalies.

1 Feb 2011